A multidisciplinary team provides an integrated approach for treatment decisions to achieve the best clinical outcomesâ€”interventional radiology, medical oncology, and surgical oncology of the critical stakeholders for individualized patient-centered treatment decisions. Randomized clinical trials with a head-to-head comparison with other treatment options, such as targeted therapies, are now unavailable. Therefore, no data suggests an optimal sequence of treatment strategies for treating metastatic neuroendocrine tumors. Therefore eligible patients are encouraged to enroll in open clinical trials.